Bulletin
Investor Alert

London Markets Open in:

BioXcel Therapeutics Inc.

NAS: BTAI

GO
/marketstate/country/us

After Hours

/zigman2/quotes/203146111/composite

$

15.59

Change

+0.59 +3.93%

Volume

Volume 154

Aug 10, 2022, 5:08 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203146111/composite

Today's close

$ 15.36

$ 15.00

Change

-0.36 -2.34%

Day low

Day high

$14.61

$15.79

Open
Open: 15.76

52 week low

52 week high

$8.80

$36.49

Open

Market cap

$429.85M

Average volume

520,176

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-4.36

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/btai

MarketWatch News on BTAI

  1. BioXcel Therapeutics started at buy with $19 stock price target at Mizuho

    7:05 a.m. July 7, 2022

    - Tomi Kilgore

  2. BioXcel Therapeutics stock price target cut to $127 from $150 at Truist

    7:29 a.m. April 5, 2021

    - Tomi Kilgore

  3. BioXcel Therapeutics price target cut to $127 from $150 at Truist Securities, stock rated buy

    6:59 a.m. April 1, 2021

    - Tonya Garcia

  4. BioXcel Therapeutics started at buy with $99 stock price target at UBS

    9:36 a.m. Feb. 1, 2021

    - Tomi Kilgore

  5. BioXcel Therapeutics stock price target raised to $120 from $71 at Canaccord Genuity

    10:11 a.m. July 21, 2020

    - Tomi Kilgore

  6. BioXcel Therapeutics stock price target raised to $64 from $26 at BMO Capital

    9:11 a.m. March 10, 2020

    - Tomi Kilgore

  7. BioXcel stock price target raised to $68 from $27 at Canaccord Genuity

    9:52 a.m. Feb. 21, 2020

    - Tomi Kilgore

  8. BioXcel stock price target raised to $26 from $21 at BMO Capital

    10:18 a.m. Jan. 16, 2020

    - Tomi Kilgore

  9. BioXcel Therapeutics started at outperform with $23 stock price target at BMO Capital

    9:45 a.m. April 2, 2018

    - Tomi Kilgore

/news/nonmarketwatch/company/us/btai

Other News on BTAI

  1. BioXcel stock falls ~9% as Q2 net loss widens

    1:24 p.m. Aug. 9, 2022

    - Seeking Alpha

  2. BioXcel Therapeutics Q2 2022 Earnings Preview

    2:24 p.m. Aug. 8, 2022

    - Seeking Alpha

  3. Notable earnings before Tuesday's open

    10:46 a.m. Aug. 8, 2022

    - Seeking Alpha

  4. 1 Beaten-Down Stock That Could Soar

    10:30 a.m. July 16, 2022

    - Motley Fool

  5. Why BioXcel Therapeutics Was a Winner This Week

    5:57 p.m. July 8, 2022

    - Motley Fool

  6. 2 Stocks Under $20 That Could Double Your Money

    11:15 a.m. May 27, 2022

    - Motley Fool

  7. Why Shares of BioXcel Therapeutics Climbed 25.2% This Week

    4:36 p.m. May 19, 2022

    - Motley Fool

  8. 10-Q: BIOXCEL THERAPEUTICS, INC.

    4:06 p.m. May 9, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  9. Why BioXcel Therapeutics Shares Went Up 12.9% This Week

    4:54 p.m. May 5, 2022

    - Motley Fool

  10. BioXcel soars on FDA approval for psychiatric therapy

    7:45 a.m. April 6, 2022

    - Seeking Alpha

  11. Loading more headlines...

Earnings Announcement

/news/pressrelease/company/us/btai

Press Releases on BTAI

  1. Best Stocks To Buy Now? 3 Health Care Stocks For Your List

    2:30 p.m. April 8, 2022

    - StockMarket.com

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.